Skip to content

Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial

Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03500107
Enrollment
40
Registered
2018-04-17
Start date
2018-10-02
Completion date
2025-12-20
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginosis, Bacterial

Keywords

Blue Light Emitting Diode, Women

Brief summary

Bacterial Vaginosis (BV) is a infectious process of the female genitourinary tract, an important health issue due to the high incidence and high rate of recurrence of the infection. Therefore, new therapeutic modalities are sought with the capacity to minimize drug side effects and reduce cases of recurrence of the disease. The objective of this study is to evaluate the clinical and microbiological response of the 401+/- 5nm blue light emitting diode (LED) in the treatment of women with bacterial vaginosis. The group of women with diagnosis of bacterial vaginosis will be submitted to the light therapy. These women will also be submitted to an evaluation and examination by a ginecologist before and after the therapy. There will also be an evaluation of the clinical condition and about the effects of the light through the questionnaire answered before and after participant's treatment. It's expected that the 41 +/- 5nm LED will destroy the VB demonstrated by laboratory examination and also improves the signs and results analyzed by the gynecologist and participants.

Detailed description

A current treatment proposal is the use of blue LED of 401 +/- 5 nm wich is a light that has antimicrobial effect when exposed to endogenous porphyrin of the pathogens. This exposition produces reactive oxygen and it causes cells death with no possibilities of resistance by the bacterium.

Interventions

DEVICEBlue Light Emitting Diode (LED) 401 +/- 5nm

The participant will be naked, in a gynecological stretcher and lithotomy position, and the apparatus of the LED will be positioned in front of the vulva and vaginal region, 5 cm away, it will be statically, externally, and supported on a tripod. The protocol will consist of only one session.

Sponsors

University of Messina
CollaboratorOTHER
Salvatore Giovanni Vitale M.D.
CollaboratorUNKNOWN
Centro de Atenção ao Assoalho Pélvico
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

• women with 18 to 65 years old and with diagnosis of bacterial vaginosis

Exclusion criteria

• women with injury seen by Pap smear, or in use of pacemaker, with diagnosis or suspicion of neoplasias, with heart diseases, pregnant or with diagnosis of epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Description of types of cells done by oncology and microflora cytology in women treated by blue LED of 401 +/- 5nm15 daysThis exam will be done by the collect of vaginal secretion to analyze types of cells and organisms
Amount of clue cells quantified by fresh cytology in vaginal secretion of women treated by blu LED of 401 +/- 5nm10 minutesThis exam will be done by the collect of vaginal secretion using KOH 10%
Value of vaginal pH measurement in women treated by blue LED2 minutesThis exam will be done by the collect of vaginal secretion using a pH measuring tape to analyse the hydrogen potential in -log 10 \[pH+\] in women treated by blue LED. It will be used the numeric scale of pH value
Identification of bacterial vaginosis by the culture in vaginal secretion of women treated by blue LED15 daysThis exam will be done by the collect of vaginal secretion using a Gram exam / culture for bacteria in women treated by blue LED

Countries

Brazil

Contacts

Primary ContactPatricia Lordelo
pvslordelo@hotmail.com+55 71 3330 1640
Backup ContactPatricia Lordelo
pvslordelo@hotmail.com+55 71 3276 8260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026